Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics in cancer therapy and nanomedicine
Annalisa Roberti, Adolfo Fernández, Ramón Torrecillas, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 365
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
Md. Sahab Uddin, Abdullah Al Mamun, Badrah S. Alghamdi, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 100-120
Closed Access | Times Cited: 139
Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders
Jan Spaas, Lieve van Veggel, Melissa Schepers, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 10, pp. 4615-4637
Open Access | Times Cited: 132
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation
Annalisa Roberti, Agustín F. Fernández, Mario F. Fraga
Molecular Metabolism (2021) Vol. 45, pp. 101165-101165
Open Access | Times Cited: 91
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
Reem Saleh, Salman M. Toor, Varun Sasidharan Nair, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Gulab Sher, Nadia Aziz Salman, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 152-165
Open Access | Times Cited: 77
Transcription and Translation Inhibitors in Cancer Treatment
Nihay Laham-Karam, Gaspar Pinto, Antti Poso, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 76
Calcium carbonate nano- and microparticles: synthesis methods and biological applications
Preksha Fadia, Simona Tyagi, Stuti Bhagat, et al.
3 Biotech (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 69
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Anna Ulldemolins, Joaquin Seras‐Franzoso, Fernanda Andrade, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 67
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
Feng Li, Syeda Qasim, Dapeng Li, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 335-352
Open Access | Times Cited: 62
Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach
Ali N. Chamseddine, Tarek Assi, Olivier Mir, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107986-107986
Closed Access | Times Cited: 61
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
Jingtong Zhang, Qianghua Zhou, Keji Xie, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 58
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Amir R. Afshari, Mehdi Sanati, Hamid Mollazadeh, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 860-872
Closed Access | Times Cited: 56
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Joe Ibrahim, Marc Peeters, Guy Van Camp, et al.
European Journal of Cancer (2022) Vol. 178, pp. 91-113
Closed Access | Times Cited: 52
Inheritance of paternal DNA damage by histone-mediated repair restriction
Siyao Wang, David H. Meyer, Björn Schumacher
Nature (2022) Vol. 613, Iss. 7943, pp. 365-374
Open Access | Times Cited: 38
Progress in the cryoablation and cryoimmunotherapy for tumor
Zenan Chen, Liangliang Meng, Jing Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
Qi Tang, Bing Yu, Lilong Gao, et al.
Current Medicinal Chemistry (2018) Vol. 25, Iss. 16, pp. 1837-1866
Closed Access | Times Cited: 68
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
Michel Montalvo-Casimiro, Rodrigo González‐Barrios, Marco Antonio Meraz-Rodriguez, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 64
Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
Verona Buociková, Iván Ríos-Mondragón, Eleftherios Pilalis, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3622-3622
Open Access | Times Cited: 54
Cryoablation and immunotherapy of cancer
Chakradhar Yakkala, Alban Denys, Lana E. Kandalaft, et al.
Current Opinion in Biotechnology (2020) Vol. 65, pp. 60-64
Closed Access | Times Cited: 51
Understanding the Interplay Between Health Disparities and Epigenomics
Viviana J. Mancilla, Noah C. Peeri, Talisa Silzer, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 51
Current paradigms in epigenetic anticancer therapeutics and future challenges
Manoj Singh, Vikas Kumar, Nirmala Sehrawat, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 422-440
Closed Access | Times Cited: 49
Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma
Qian‐Ying Zhu, Gexin Zhao, Yan Li, et al.
MedComm (2021) Vol. 2, Iss. 2, pp. 175-206
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top